PET Guided Seed Implant for Tumors
Part of Cancer clinical trials.
This study uses PET/CT scans to map the exact location of your tumor and plan the best dose of radioactive seeds. The goal is to kill the tumor more precisely while reducing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a solid tumor, lymphoma, or leukemia with a spot that can be reached for seed implant.
- Your tumor can be seen on a PET/CT scan.
- Your doctor expects you to live at least 6 more months.
- You are not pregnant or breastfeeding, and have no uncontrolled infections or severe heart/lung problems.
- You have no bleeding issues or allergies to the imaging agents used in this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether placing tiny radioactive seeds directly into a tumor, combined with immunotherapy (a drug that helps your immune system attack cancer), can help treat cancers that are new, have come back, or have spread. It's for people who can safely have the seed procedure and are eligible for immunotherapy.
This trial tests a treatment that places tiny radioactive seeds directly into some of your tumors, combined with your usual cancer therapy. It is for people who have 6 to 10 tumors that have spread to other parts of the body (not the brain). The goal is to see if adding this implant procedure helps control the tumors better.
This trial tests a combination of two local treatments—radioactive seed implants and cryoablation (freezing)—for people with cancer that has spread to multiple sites or created large tumors that can't be surgically removed. The goal is to see if targeting up to five specific spots can control the disease and reduce symptoms.
This trial tests a procedure where tiny radioactive seeds are placed into spinal tumors to relieve pain and control growth. It is for people with cancer that has spread to the bone and who are able to undergo the procedure safely.
This trial tests a procedure that places tiny radioactive seeds directly into tumors that have started growing again in patients with lung or colorectal cancer that has spread. It combines this with standard drug therapy to see if it can better control the disease.
This early-phase study tests a precise, targeted radiation treatment for prostate cancer, using a special PET scan to help plan exactly where to treat. It may help reduce the amount of radiation to surrounding tissues while treating the cancer.
Hear when a new Malignant Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.